Literature DB >> 19331181

Release of volatile organic compounds from the lung cancer cell line NCI-H2087 in vitro.

Andreas Sponring1, Wojciech Filipiak, Tomas Mikoviny, Clemens Ager, Jochen Schubert, Wolfram Miekisch, Anton Amann, Jakob Troppmair.   

Abstract

AIM: The aim of this work was to confirm the existence of volatile organic compounds (VOCs) specifically released by lung cancer cells.
MATERIALS AND METHODS: NCI-H2087 cells were trypsinized and 100 x 10(6) cells were incubated in a sealed fermenter overnight. Samples from the headspace of the culture vessel were collected with simultaneous preconcentration by adsorption on solid sorbents and subsequently thermodesorbed for analysis by gas chromatography mass spectrometry (GC-MS).
RESULTS: The results showed a significant increase in the concentration of 2-ethyl-1-hexanol and 2-methylpentane in the headspace as compared with medium controls. 2-Methylpentane is also found in exhaled breath of lung cancer patients in contrast to that from healthy volunteers. Statistically significantly lower abundances of acetaldehyde, 2-methylpropanal, 3-methylbutanal, 2-methylbutanal and butyl acetate were found.
CONCLUSION: Our findings demonstrate that certain compounds can be cancer cell derived and thus may be indicative of the presence of a tumor. Some compounds were not released but seem to be consumed by cancer cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19331181

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  41 in total

1.  Exhaled breath analysis with a colorimetric sensor array for the identification and characterization of lung cancer.

Authors:  Peter J Mazzone; Xiao-Feng Wang; Yaomin Xu; Tarek Mekhail; Mary C Beukemann; Jie Na; Jonathan W Kemling; Kenneth S Suslick; Madhu Sasidhar
Journal:  J Thorac Oncol       Date:  2012-01       Impact factor: 15.609

2.  Volatile metabolomic signature of bladder cancer cell lines based on gas chromatography-mass spectrometry.

Authors:  Daniela Rodrigues; Joana Pinto; Ana Margarida Araújo; Sara Monteiro-Reis; Carmen Jerónimo; Rui Henrique; Maria de Lourdes Bastos; Paula Guedes de Pinho; Márcia Carvalho
Journal:  Metabolomics       Date:  2018-04-17       Impact factor: 4.290

3.  Dependence of exhaled breath composition on exogenous factors, smoking habits and exposure to air pollutants.

Authors:  W Filipiak; V Ruzsanyi; P Mochalski; A Filipiak; A Bajtarevic; C Ager; H Denz; W Hilbe; H Jamnig; M Hackl; A Dzien; A Amann
Journal:  J Breath Res       Date:  2012-09       Impact factor: 3.262

Review 4.  Sniffer dogs as part of a bimodal bionic research approach to develop a lung cancer screening.

Authors:  Enole Boedeker; Godehard Friedel; Thorsten Walles
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-02-17

5.  Bronchoscopically obtained volatile biomarkers in lung cancer.

Authors:  Kaid Darwiche; Joerg Ingo Baumbach; Urte Sommerwerck; Helmut Teschler; Lutz Freitag
Journal:  Lung       Date:  2011-10-04       Impact factor: 2.584

6.  Noninvasive detection of lung cancer by analysis of exhaled breath.

Authors:  Amel Bajtarevic; Clemens Ager; Martin Pienz; Martin Klieber; Konrad Schwarz; Magdalena Ligor; Tomasz Ligor; Wojciech Filipiak; Hubert Denz; Michael Fiegl; Wolfgang Hilbe; Wolfgang Weiss; Peter Lukas; Herbert Jamnig; Martin Hackl; Alfred Haidenberger; Bogusław Buszewski; Wolfram Miekisch; Jochen Schubert; Anton Amann
Journal:  BMC Cancer       Date:  2009-09-29       Impact factor: 4.430

7.  Urinary volatile compounds as biomarkers for lung cancer: a proof of principle study using odor signatures in mouse models of lung cancer.

Authors:  Koichi Matsumura; Maryanne Opiekun; Hiroaki Oka; Anil Vachani; Steven M Albelda; Kunio Yamazaki; Gary K Beauchamp
Journal:  PLoS One       Date:  2010-01-27       Impact factor: 3.240

8.  Classification of lung cancer histology by gold nanoparticle sensors.

Authors:  Orna Barash; Nir Peled; Ulrike Tisch; Paul A Bunn; Fred R Hirsch; Hossam Haick
Journal:  Nanomedicine       Date:  2011-10-25       Impact factor: 5.307

9.  The effects of neuroblastoma and chemotherapy on metabolism, fecal microbiome, volatile organic compounds, and gut barrier function in a murine model.

Authors:  Christoph Castellani; Georg Singer; Margarita Eibisberger; Beate Obermüller; Gert Warncke; Wolfram Miekisch; Dagmar Kolb-Lenz; Gregor Summer; Theresa M Pauer; Ahmed ElHaddad; Karl Kashofer; Holger Till
Journal:  Pediatr Res       Date:  2019-01-16       Impact factor: 3.756

10.  Assessment of the exhalation kinetics of volatile cancer biomarkers based on their physicochemical properties.

Authors:  Anton Amann; Pawel Mochalski; Vera Ruzsanyi; Yoav Y Broza; Hossam Haick
Journal:  J Breath Res       Date:  2014-02-24       Impact factor: 3.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.